Clinical Baseline Characteristics and Hemodynamic Parameters
| Parameter | n |
|---|---|
| No. of patients (men) | 10 (9) |
| Age (y), mean ± SD | 51 ± 8 |
| NYHA functional class | |
| I | 2 |
| II | 4 |
| III | 4 |
| Medication | |
| ACE inhibitors | 9 |
| AT type 1 receptor antagonists | 1 |
| Diuretics | 6 |
| Digitalis | 7 |
| β-Blockers | 10 |
| LVEF (echo) (%) | |
| Mean ± SD | 30 ± 7 |
| Range | 17–40 |
| LVEDD (echo) (mm) | |
| Mean ± SD | 67 ± 7 |
| Follow-up (mo) | |
| Mean ± SD | 13 ± 3 |
| Range | 8–18 |
| Median | 11.5 |
NYHA = New York Heart Association; AT = angiotensin II; echo = echocardiographic.